Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.640
+0.050 (3.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $155.56 million as of December 20, 2024. Its market cap has decreased by -0.41% in one year.
Market Cap
155.56M
Enterprise Value
90.91M
1-Year Change
-0.41%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $155.56M, a decrease of -88.42%. That is a compound annual growth rate of -19.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 164.20M | -4.09% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro-Dex | 158.86M |
| Ventyx Biosciences | 158.39M |
| Corbus Pharmaceuticals Holdings | 158.33M |
| Nanobiotix | 158.11M |
| Seres Therapeutics | 156.31M |
| Sutro Biopharma | 155.02M |
| Adaptimmune Therapeutics | 154.78M |
| The Joint | 153.88M |